CClinicalTrials.gg
CompletedNCT01224158Updated Dec 4, 2019Results posted

Study of an Experimental Toothbrush for Treatment and Prevention of Gingivitis

An interventional study of Experimental Power Toothbrush and Flat trimmed Manual Toothbrush in Dental Devices, Home Care, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-12-04.

Sponsored by Johnson & Johnson Consumer and Personal Products Worldwide · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
153
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is 6 weeks long with 6 visits to a clinical site. People participating in this study will be asked to brush their teeth two times a day with a provided toothbrush. For one of those six weeks people will be asked to rinse with a mouthwash. During that time, people will use the mouthwash two times a day and will not be allowed to brush their teeth at all. The mouth, teeth, tongue and gums will be looked at by a dentist. At each visit, people will rinse with a pink liquid that will dye their mouths pink. The dye is temporary and will go away by the end of the day. They may also be asked to complete a short questionnaire about their experience.

Read the detailed description

This is a 42-day, randomized, observer-blind, parallel group, single-center clinical trial. Generally healthy adults will be recruited from a database of known plaque formers. A sufficient number of subjects meeting the necessary inclusion/exclusion criteria will be enrolled into two groups, so that 140 subjects (70 per treatment group) would reasonably be expected to complete the study.

The study will have a pre-experimental phase, which will last 2 weeks followed by an experimental phase that is 4 weeks in duration. At the start of the pre-experimental phase (Day 0), subjects will undergo an initial oral exam, during which gingivitis and pre-brushing plaque evaluations will be performed. Supragingival plaque levels will be assessed on all scorable teeth according to the Rustogi Modified Navy Plaque Index (RMNPI) and gingivitis will be scored according to the Modified Gingival Index (MGI). Subjects with a whole mouth mean plaque level > 0.60 and a whole mouth mean MGI ≥ 1.75 will then brush their teeth with their assigned toothbrush using American Dental Association (ADA) Accepted fluoride toothpaste. They will be provided with written and verbal instructions to use their toothbrush twice a day, for the next 7 days (Normalization period), allowing the participants to get familiar with the assigned test product. During the second visit (Day 7), the subjects will return the products to the clinical site, and start the experimental gingivitis phase, during which they will only be allowed to use a placebo rinse (W002194-0221P) as means of oral hygiene. The objective of the experimental gingivitis phase is to standardize the levels of plaque and gingivitis in both groups.

At visit 3 (Day 14), subjects will undergo a second gingivitis and pre-brushing plaque evaluation and receive their assigned brush, instructions and diary. They will brush with their assigned toothbrush for two weeks (14 days), using an ADA accepted fluoride toothpaste. During the fourth visit (Day 28), the subjects will return to the site and undergo a third gingivitis and post-brushing plaque evaluation. At the last visit (Day 42), the study participants will undergo final gingivitis and post-brushing plaque evaluations and return all used products.

02

Conditions studied

  • Dental Devices, Home Care

Browse trials for

03

In context

Gingivitis

590 studies on the registry are indexed under Gingivitis; 104 are open to participants now.

This study's enrollment of 153 is above the median of 64 across 478 interventional studies indexed under Gingivitis.

Browse Gingivitis studies →

Lead sponsor

Johnson & Johnson Consumer and Personal Products Worldwide is the lead sponsor of 58 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Males and females at least 18 years of age and in good general and oral health.
  • Evidence of a personally signed and dated informed consent document indicating the subject (or legally acceptable representative) has been informed of all pertinent aspects of the trial.
  • Willingness to use the assigned products according to instructions, availability for appointments and likelihood of completing the clinical trial.
  • Good general and oral health with manual dexterity.
  • Willingness to refrain from all oral hygiene procedures within 18-24 hours prior to the study visit.
  • A minimum of twenty scorable teeth with at least one scorable molar in each quadrant.
  • A whole-mouth mean plaque level greater than 0.60 at Day 0.
  • Whole-mouth-mean gingivitis level greater than or equal to 1.75 at Day 0.
  • Absence of orthodontic bands, appliances, bridges, numerous crowns, extensive large restorations, excessive caries, removable orthodontic appliances or partial dentures.
  • Absence of significant oral soft tissue pathology, excluding gingivitis, based on the visual oral examination and at the discretion of the examiner.
  • Adequate oral hygiene (i.e., brush teeth daily and exhibit no signs of oral neglect).
  • Absence of moderate/advanced periodontitis.
  • Absence of extensive supragingival calculus.
  • Absence of ulcerations on lips and oral mucosa.

Exclusion criteria

Exclusion Criteria:

  • Currently taking steroids, antibiotic medication or any other medication within the previous month that may interfere with the efficacy evaluations.
  • Those requiring antibiotic premedication prior to dental treatment.
  • Participation in a dental clinical trial involving oral care products currently or within the past 28 days.
  • Dental prophylaxis within one week prior to enrollment into the study.
  • Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or investigational product administration or may interfere with the interpretation of trial results and, in the judgment of the investigator, would make the subject inappropriate for entry into this trial.
  • Physical limitations or restrictions that might preclude use of normal oral hygiene procedures (i.e., toothbrushing, etc.).
  • Self-reported pregnant or lactating women.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
153 participants (actual)

Study arms

  • Experimental
    PR-009577 Toothbrush

    Experimental Power Toothbrush

    Device: Experimental Power Toothbrush

  • Active comparator
    PR-000172 Toothbrush

    Flat trimmed Manual Toothbrush

    Device: Flat trimmed Manual Toothbrush

Interventions

  • DeviceExperimental Power Toothbrush

    Following a placebo mouthwash phase, Subjects will be asked to brush their teeth (twice per day with the experimental toothbrush and toothpaste provided) moving to the next quadrant of the mouth at 30-second intervals.

    Also known as: Not yet marketed

  • DeviceFlat trimmed Manual Toothbrush

    Following a placebo mouthwash phase, Subjects will be asked to brush their teeth (twice per day using the toothbrush and toothpaste provided) in their usual manner.

    Also known as: Reach®

06

What researchers measure

Primary outcomes

  1. Whole-mouth Mean Modified Gingival Index (MGI) Score at Day 42

    Gingivitis was assessed by the Modified Gingival Index on the buccal and lingual marginal gingiva and interdental papillae of all scorable teeth by the dental examiner using following scale score range from 0 to 4, where 0 - Normal (absence of inflammation); 1 - Mild inflammation (slight change in color, little change in texture) of any portion of the gingival unit; 2 - Mild inflammation of the entire gingival unit; 3 - Moderate inflammation (moderate glazing, redness, edema, and/or hypertrophy) of the gingival unit; 4 - Severe inflammation (marked redness and edema/hypertrophy, spontaneous bleeding, or ulceration) of the gingival unit.

    Time frame: Day 42

Secondary outcomes

  1. Whole-mouth Mean Modified Gingival Index (MGI) Score at Day 28

    Gingivitis was assessed by the Modified Gingival Index on the buccal and lingual marginal gingiva and interdental papillae of all scorable teeth by the dental examiner using following scale with score range from 0 to 4, where 0 - Normal (absence of inflammation); 1 - Mild inflammation (slight change in color, little change in texture) of any portion of the gingival unit; 2 - Mild inflammation of the entire gingival unit; 3 - Moderate inflammation (moderate glazing, redness, edema, and/or hypertrophy) of the gingival unit; 4 - Severe inflammation (marked redness and edema/hypertrophy, spontaneous bleeding, or ulceration) of the gingival unit.

    Time frame: Day 28

  2. Whole-mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 42

    Supra-gingival plaque was assessed on the facial and lingual surfaces of the teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along the gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across the middle of the tooth and I covers the incisal area. Plaque was assigned on one of the following score: 0 represents no dental plaque and 1 represents plaque present in the measured segment of the tooth. Mean RMNPI overall was calculated for each participant as the total score for all tooth sites assessed divided by the total number of tooth sites assessed.

    Time frame: Day 42

  3. Whole-Mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 28

    Supra-gingival plaque was assessed on the facial and lingual surfaces of the teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along the gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across the middle of the tooth and I covers the incisal area. Plaque was assigned on one of the following score: 0 represents no dental plaque and 1 represents plaque present in the measured segment of the tooth. Mean RMNPI overall was calculated for each participant as the total score for all tooth sites assessed divided by the total number of tooth sites assessed.

    Time frame: Day 28

  4. Hard-to-reach Mean Rustogi Modified Navy Plaque Index (RMNPI) at Day 28 and 42

    Hard-to-reach mean score is defined as mean of scores over following areas combined; a) Gingival margin (Sites A - C); b) Distal Molars (F for teeth 2, 15, 18, and 31 or the most posterior molar in that quadrant); c) Lingual of the mandibular incisors (Teeth 23-26, lingual); d) Interproximal (Sites D and F); e) Mandibular posterior lingual (Teeth 18-21, 28-31, lingual). Supra-gingival plaque was assessed on facial and lingual surfaces of teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across middle of tooth and I covers incisal area. Plaque was disclosed on a scale (0 indicates no dental plaque to 1 indicates dental plaque), Mean RPI overall was calculated for each participant as total score for all tooth sites assessed divided by total number of tooth sites assessed.

    Time frame: Day 28 and 42

  5. Mean Rustogi Modified Navy Plaque Index (RMNPI) at Day 28 and 42 for Each Hard-to-reach Area

    Hard-to-reach mean score is defined as mean of scores over following areas separately d; a) Gingival margin (Sites A - C); b) Distal Molars (F for teeth 2, 15, 18, and 31 or the most posterior molar in that quadrant); c) Lingual of the mandibular incisors (Teeth 23-26, lingual); d) Interproximal (Sites D and F); e) Mandibular posterior lingual (Teeth 18-21, 28-31, lingual). Supra-gingival plaque was assessed on facial and lingual surfaces of teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across middle of tooth and I covers incisal area. Plaque on each area was assigned one of the following score: on a scale (0 indicates no dental plaque and 1 indicates plaque present in the measured segment of the tooth).

    Time frame: Day 28 and 42

07

Results

Posted Dec 4, 2019
Limitations and caveats
No study limitations were reported.

Participant flow

Participant flow — Overall Study
MilestoneManual Toothbrush (PR-000172)Power Toothbrush (PR-009577)
Started7677
Completed7577
Not completed10
Withdrew: Withdrawal by subject10

Outcome measures

PrimaryWhole-mouth Mean Modified Gingival Index (MGI) Score at Day 42

Gingivitis was assessed by the Modified Gingival Index on the buccal and lingual marginal gingiva and interdental papillae of all scorable teeth by the dental examiner using following scale score range from 0 to 4, where 0 - Normal (absence of inflammation); 1 - Mild inflammation (slight change in color, little change in texture) of any portion of the gingival unit; 2 - Mild inflammation of the entire gingival unit; 3 - Moderate inflammation (moderate glazing, redness, edema, and/or hypertrophy) of the gingival unit; 4 - Severe inflammation (marked redness and edema/hypertrophy, spontaneous bleeding, or ulceration) of the gingival unit.

Time frame:
Day 42
Reported as:
Mean · Unit on a scale
Whole-mouth Mean Modified Gingival Index (MGI) Score at Day 42
Unit on a scaleManual Toothbrush (PR-000172)Power Toothbrush (PR-009577)
Whole-mouth Mean Modified Gingival Index (MGI) Score at Day 421.880 ± 0.12231.770 ± 0.1443
SecondaryWhole-mouth Mean Modified Gingival Index (MGI) Score at Day 28

Gingivitis was assessed by the Modified Gingival Index on the buccal and lingual marginal gingiva and interdental papillae of all scorable teeth by the dental examiner using following scale with score range from 0 to 4, where 0 - Normal (absence of inflammation); 1 - Mild inflammation (slight change in color, little change in texture) of any portion of the gingival unit; 2 - Mild inflammation of the entire gingival unit; 3 - Moderate inflammation (moderate glazing, redness, edema, and/or hypertrophy) of the gingival unit; 4 - Severe inflammation (marked redness and edema/hypertrophy, spontaneous bleeding, or ulceration) of the gingival unit.

Time frame:
Day 28
Reported as:
Mean · Unit on a scale
Whole-mouth Mean Modified Gingival Index (MGI) Score at Day 28
Unit on a scaleManual Toothbrush (PR-000172)Power Toothbrush (PR-009577)
Whole-mouth Mean Modified Gingival Index (MGI) Score at Day 281.957 ± 0.12251.868 ± 0.1287
SecondaryWhole-mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 42

Supra-gingival plaque was assessed on the facial and lingual surfaces of the teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along the gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across the middle of the tooth and I covers the incisal area. Plaque was assigned on one of the following score: 0 represents no dental plaque and 1 represents plaque present in the measured segment of the tooth. Mean RMNPI overall was calculated for each participant as the total score for all tooth sites assessed divided by the total number of tooth sites assessed.

Time frame:
Day 42
Reported as:
Mean · Units on a scale
Whole-mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 42
Units on a scaleManual Toothbrush (PR-000172)Power Toothbrush (PR-009577)
Whole-mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 420.146 ± 0.07100.131 ± 0.0633
SecondaryWhole-Mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 28

Supra-gingival plaque was assessed on the facial and lingual surfaces of the teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along the gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across the middle of the tooth and I covers the incisal area. Plaque was assigned on one of the following score: 0 represents no dental plaque and 1 represents plaque present in the measured segment of the tooth. Mean RMNPI overall was calculated for each participant as the total score for all tooth sites assessed divided by the total number of tooth sites assessed.

Time frame:
Day 28
Reported as:
Mean · Units on a scale
Whole-Mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 28
Units on a scaleManual Toothbrush (PR-000172)Power Toothbrush (PR-009577)
Whole-Mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 280.164 ± 0.07550.148 ± 0.0762
SecondaryHard-to-reach Mean Rustogi Modified Navy Plaque Index (RMNPI) at Day 28 and 42

Hard-to-reach mean score is defined as mean of scores over following areas combined; a) Gingival margin (Sites A - C); b) Distal Molars (F for teeth 2, 15, 18, and 31 or the most posterior molar in that quadrant); c) Lingual of the mandibular incisors (Teeth 23-26, lingual); d) Interproximal (Sites D and F); e) Mandibular posterior lingual (Teeth 18-21, 28-31, lingual). Supra-gingival plaque was assessed on facial and lingual surfaces of teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across middle of tooth and I covers incisal area. Plaque was disclosed on a scale (0 indicates no dental plaque to 1 indicates dental plaque), Mean RPI overall was calculated for each participant as total score for all tooth sites assessed divided by total number of tooth sites assessed.

Time frame:
Day 28 and 42
Reported as:
Mean · Units on a scale
Hard-to-reach Mean Rustogi Modified Navy Plaque Index (RMNPI) at Day 28 and 42
Units on a scaleManual Toothbrush (PR-000172)Power Toothbrush (PR-009577)
Day 280.232 ± 0.10660.209 ± 0.1067
Day 420.208 ± 0.09930.186 ± 0.0905
SecondaryMean Rustogi Modified Navy Plaque Index (RMNPI) at Day 28 and 42 for Each Hard-to-reach Area

Hard-to-reach mean score is defined as mean of scores over following areas separately d; a) Gingival margin (Sites A - C); b) Distal Molars (F for teeth 2, 15, 18, and 31 or the most posterior molar in that quadrant); c) Lingual of the mandibular incisors (Teeth 23-26, lingual); d) Interproximal (Sites D and F); e) Mandibular posterior lingual (Teeth 18-21, 28-31, lingual). Supra-gingival plaque was assessed on facial and lingual surfaces of teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across middle of tooth and I covers incisal area. Plaque on each area was assigned one of the following score: on a scale (0 indicates no dental plaque and 1 indicates plaque present in the measured segment of the tooth).

Time frame:
Day 28 and 42
Reported as:
Mean · Units on a scale
Mean Rustogi Modified Navy Plaque Index (RMNPI) at Day 28 and 42 for Each Hard-to-reach Area
Units on a scaleManual Toothbrush (PR-000172)Power Toothbrush (PR-009577)
Gingival Margin: Day 280.298 ± 0.11720.271 ± 0.1169
Gingival Margin: Day 420.273 ± 0.11810.246 ± 0.0992
Distal Molars: Day 280.413 ± 0.25990.399 ± 0.2175
Distal Molars: Day 420.352 ± 0.21720.339 ± 0.2284
Lingual of the Mandibular Incisors: Day 280.190 ± 0.25010.149 ± 0.2430
Lingual of the Mandibular Incisors: Day 420.152 ± 0.18920.119 ± 0.2035
Interproximal: Day 280.195 ± 0.11730.169 ± 0.1122
Interproximal: Day 420.171 ± 0.10470.148 ± 0.1054
Mandibular Posterior Lingual: Day 280.368 ± 0.18080.372 ± 0.1888
Mandibular Posterior Lingual: Day 420.351 ± 0.17890.336 ± 0.1473

Adverse events

Collected over Up to 6 weeks. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Manual Toothbrush (PR-000172)0/76 (0%)0/76 (0%)0/76 (0%)
Power Toothbrush (PR-009577)0/77 (0%)0/77 (0%)0/77 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Manual Toothbrush (PR-000172)Power Toothbrush (PR-009577)Total
Mean32.4 ± 10.2132.9 ± 9.6132.7 ± 9.89
Sex: Female, Male
Sex: Female, Male(Participants)Manual Toothbrush (PR-000172)Power Toothbrush (PR-009577)Total
Female424688
Male343165
Region of Enrollment
Region of Enrollment(Participants)Manual Toothbrush (PR-000172)Power Toothbrush (PR-009577)Total
United States — USA7677153
08

Study locations

1 site
  • BioSci Research America
    Las Vegas, Nevada 89121, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01224158
Lead sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Responsible party
Sponsor
First posted
Oct 19, 2010
Start date
Sep 13, 2010
Primary completion
Oct 29, 2010
Completion
Oct 29, 2010
Results posted
Dec 4, 2019
Last update
Dec 4, 2019

Study contacts

Marcelo Araujo
study director · Johnson & Johnson Consumer and Personal Products Worldwide

Oversight

Data monitoring committee
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion